Biogen Idec Inc. · Weston, MA United States (NASDAQ: BIIB)
| 133 Boston Post Rd. | Phone: 781-464-2000 |
| Weston, MA | Fax: 617-679-2617 |
| 02493 | |
| United States | 
Map This Company |
Biogen Idec Inc. Rankings
 #476 in FORTUNE 500 (May 2011) | S&P 500 |
More Companies in These Related Industries: Pharmaceutical Preparation MfgCompany Description
With its pipeline full of biotech drugs, Biogen Idec aims to meet the unmet needs of patients around the world. The biotech giant is focused on developing treatments in the areas of immunology and neurology. Its product roster includes best-selling Avonex, a popular drug for the treatment of relapsing multiple sclerosis (MS); Tysabri, a drug treatment for MS and Crohn's disease (developed with
Biogen Idec Inc. Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Public - NASDAQ: BIIB Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2011 Employees | 5,000 |
Executives
116 executives listed for Biogen Idec Inc.'s Weston, MA location.
| Chairman | William Young | |
|---|---|---|
| CEO and Director | George Scangos | |
| EVP and CFO | Paul Clancy |